Royal Society Open Science (May 2022)

The regulatory landscape of retinoblastoma: a pathway analysis perspective

  • Laura Gómez-Romero,
  • Diana E. Alvarez-Suarez,
  • Enrique Hernández-Lemus,
  • M. Verónica Ponce-Castañeda,
  • Hugo Tovar

DOI
https://doi.org/10.1098/rsos.220031
Journal volume & issue
Vol. 9, no. 5

Abstract

Read online

Retinoblastoma (Rb) is a rare intraocular tumour in early childhood, with an approximate incidence of 1 in 18 000 live births. Experimental studies for Rb are complex due to the challenges associated with obtaining a normal retina to contrast with diseased tissue. In this work, we reanalyse a dataset that contains normal retina samples. We identified the individual genes whose expression is different in Rb in contrast with normal tissue, determined the pathways whose global expression pattern is more distant from the global expression observed in normal tissue, and finally, we identified which transcription factors regulate the highest number of differentially expressed genes (DEGs) and proposed as transcriptional master regulators (TMRs). The enrichment of DEGs in the phototransduction and retrograde endocannabinoid signalling pathways could be associated with abnormal behaviour of the processes leading to cellular differentiation and cellular proliferation. On the other hand, the TMRs nuclear receptor subfamily 5 group A member 2 and hepatocyte nuclear factor 4 gamma are involved in hepatocyte differentiation. Therefore, the enrichment of aberrant expression in these transcription factors could suggest an abnormal retina development that could be involved in Rb origin and progression.

Keywords